Coulter Partners successfully places Valerio Ferri as ExoLab Italia’s new CEO
LONDON, UK, and MILAN, Italy, September 16, 2025 – Coulter Partners, the global expert in building leadership teams for Health, Science and Technology innovation businesses, is proud of the successful placement of Valerio Ferri as Chief Executive Officer (CEO) at ExoLab Italia.
ExoLab Italia is a biotech company producing plant-based exosomes for the cosmetics, nutraceutical, and pharmaceutical markets.
With extensive experience in the nutraceutical and pharmaceutical sectors, Valerio Ferri joins ExoLab Italia after holding senior roles in leading companies such as Biofarma Group, where he led the Sales & Marketing functions, bringing the group to a turnover of over 436 million euros, and Fidia Farmaceutici (where he developed the Contract Development Manufacturer – CDMO), contributing to significant growth. Additionally, he held a strategic role at Fareva, the world’s second-largest CDMO manufacturer, strengthening his expertise in managing large global accounts and international growth. His background includes M&A, internationalization, and strategic development.
“I am thrilled to join ExoLab Italia at such a dynamic moment in its history. Plant-based exosomes represent an extraordinary frontier in biotechnological innovation, and I am confident that, thanks to the team’s exceptional scientific and industrial know-how, we will be able to consolidate our leadership in Europe and expand globally,” commented Valerio Ferri.
Valerio Carconi, head of Sales & Marketing at ExoLab Italia further added: “Finding a leader with the precise combination of commercial acumen, technical expertise, and an understanding of our unique market was a significant challenge. Coulter Partners not only understood our specific needs but also expertly navigated the complexities of our location to find the perfect candidate. Their dedicated approach was instrumental in securing Valerio for this pivotal role.”
[ENDS]
Notes to editors:
About ExoLab Italia
ExoLab Italia is an innovative biotech company that produces new raw materials derived from plant exosomes, sourced from organic Italian agriculture. With a foundation built on two decades of exosome research, the company is committed to revolutionizing the nutraceutical and dermocosmetic industries. Driven by a passion for fundamental scientific inquiry and a desire to create groundbreaking products, ExoLab Italia combines advanced innovation with a core commitment to sustainability.
For further information: www.exolabitalia.net
About Coulter Partners
We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
